News

Fri, 16/02/2018
Muenster scientists present their latest research
Muenster.  The Scientific Retreat of the SFB CRC-TR 128 will be held on the 9th and 10th of March 2018. PhD students and young postdocs from all labs of the Department of Neurology and Insititute for Translational Neurology in Münster will give short oral presentations summarizing their main ongoing projects. Sessions will be introduced by […]...more
Fri, 16/02/2018
Ion channels in autoimmune neurodegeneration
Muenster. Autoaggressive T Lymphocytes that have to cross the activated blood brain barrier (BBB) play an important role in the pathogenesis of MS. Prof. Sven Meuth, principal investigator in the DFG-funded cluster of excellence “Cells in Motion” and the CRC 128 “Multiple Sclerosis” focusses on the potassium channel TREK-1. It analyses the molecular pathways through […]...more
Fri, 16/02/2018
Introduction into Histopathology of MS
Muenster, The CRC-128 „Multiple Sclerosis“ offers an histopathology course for its members. The two-day seminar is open for nine selected participants who will get the chance to learn neuropathology techniques and join a microscopy session. Where?: Institute of Neuropathology, Pottkamp 2, 48149 Muenster When?: April 26-27, 2018 flyer histopathology muenster 2018  ...more


Thu, 09/11/2017 | Elisabeth Schuh received SEED funding

Munich. SFB 128 researcher Elisabeth Schuh, MD, has been honoured by a young scientist’s studentship within the KKNMS SEED program. In her project „The role of the NLRP3 inflammasome in multiple sclerosis and experimental autoimmune encephalomyelitis“, Dr. Schuh analyses the influence of the NLRP3in MS. NLRP is a cytosolic protein complex in monocytes, macrophages and neutrophil granolucytes that regulated the production of inflammatory cytokines of the interleukin-1 family. In her project, Dr. Schuh wants to identify the population of myeloid cells involved in MS pathogenesis, with the aim of finding new pathways for therapeutic intervention that prevent autoimmune tissue damage.
The SEED program addresses scientists younger than 32 years who have not yet completed their medical training. The maximum funding is 32.000 € or 75 percent of the project’s budget. The remaining 25% have to be paid by the stipend’s employee.